Cancer Immunotherapy
James Allison Β· Glen Dranoff
ΠΌΠ°Ρ 2006. Β· Advances in Immunology 90. ΠΊΡΠΈΠ³Π° Β· Elsevier
Π-ΠΊΡΠΈΠ³Π°
400
Π‘ΡΡΠ°Π½ΠΈΡΠ°
family_home
ΠΡΠΏΡΡΠ°Π²Π° ΡΡΠ»ΠΎΠ²Π΅
info
reportΠΡΠ΅Π½Π΅ ΠΈ ΡΠ΅ΡΠ΅Π½Π·ΠΈΡΠ΅ Π½ΠΈΡΡ Π²Π΅ΡΠΈΡΠΈΠΊΠΎΠ²Π°Π½Π΅ Β Π‘Π°Π·Π½Π°ΡΡΠ΅ Π²ΠΈΡΠ΅
Π ΠΎΠ²ΠΎΡ Π΅-ΠΊΡΠΈΠ·ΠΈ
For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens. This thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research.
ΠΡΠ΅Π½ΠΈΡΠ΅ ΠΎΠ²Ρ Π΅-ΠΊΡΠΈΠ³Ρ
ΠΠ°Π²ΠΈΡΠ΅ Π½Π°ΠΌ ΡΠ²ΠΎΡΠ΅ ΠΌΠΈΡΡΠ΅ΡΠ΅.
ΠΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡΠ΅ ΠΎ ΡΠΈΡΠ°ΡΡ
ΠΠ°ΠΌΠ΅ΡΠ½ΠΈ ΡΠ΅Π»Π΅ΡΠΎΠ½ΠΈ ΠΈ ΡΠ°Π±Π»Π΅ΡΠΈ
ΠΠ½ΡΡΠ°Π»ΠΈΡΠ°ΡΡΠ΅ Π°ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΡΡ Google Play ΠΊΡΠΈΠ³Π΅ Π·Π° Android ΠΈ iPad/iPhone. ΠΡΡΠΎΠΌΠ°ΡΡΠΊΠΈ ΡΠ΅ ΡΠΈΠ½Ρ
ΡΠΎΠ½ΠΈΠ·ΡΡΠ΅ ΡΠ° Π½Π°Π»ΠΎΠ³ΠΎΠΌ ΠΈ ΠΎΠΌΠΎΠ³ΡΡΠ°Π²Π° Π²Π°ΠΌ Π΄Π° ΡΠΈΡΠ°ΡΠ΅ ΠΎΠ½Π»Π°ΡΠ½ ΠΈ ΠΎΡΠ»Π°ΡΠ½ Π³Π΄Π΅ Π³ΠΎΠ΄ Π΄Π° ΡΠ΅ Π½Π°Π»Π°Π·ΠΈΡΠ΅.
ΠΠ°ΠΏΡΠΎΠΏΠΎΠ²ΠΈ ΠΈ ΡΠ°ΡΡΠ½Π°ΡΠΈ
ΠΠΎΠΆΠ΅ΡΠ΅ Π΄Π° ΡΠ»ΡΡΠ°ΡΠ΅ Π°ΡΠ΄ΠΈΠΎ-ΠΊΡΠΈΠ³Π΅ ΠΊΡΠΏΡΠ΅Π½Π΅ Π½Π° Google Play-Ρ ΠΏΠΎΠΌΠΎΡΡ Π²Π΅Π±-ΠΏΡΠ΅Π³Π»Π΅Π΄Π°ΡΠ° Π½Π° ΡΠ°ΡΡΠ½Π°ΡΡ.
Π-ΡΠΈΡΠ°ΡΠΈ ΠΈ Π΄ΡΡΠ³ΠΈ ΡΡΠ΅ΡΠ°ΡΠΈ
ΠΠ° Π±ΠΈΡΡΠ΅ ΡΠΈΡΠ°Π»ΠΈ Π½Π° ΡΡΠ΅ΡΠ°ΡΠΈΠΌΠ° ΠΊΠΎΡΠ΅ ΠΊΠΎΡΠΈΡΡΠ΅ Π΅-ΠΌΠ°ΡΡΠΈΠ»ΠΎ, ΠΊΠ°ΠΎ ΡΡΠΎ ΡΡ Kobo Π΅-ΡΠΈΡΠ°ΡΠΈ, ΡΡΠ΅Π±Π° Π΄Π° ΠΏΡΠ΅ΡΠ·ΠΌΠ΅ΡΠ΅ ΡΠ°ΡΠ» ΠΈ ΠΏΡΠ΅Π½Π΅ΡΠ΅ΡΠ΅ Π³Π° Π½Π° ΡΡΠ΅ΡΠ°Ρ. ΠΡΠ°ΡΠΈΡΠ΅ Π΄Π΅ΡΠ°ΡΠ½Π° ΡΠΏΡΡΡΡΠ²Π° ΠΈΠ· ΡΠ΅Π½ΡΡΠ° Π·Π° ΠΏΠΎΠΌΠΎΡ Π΄Π° Π±ΠΈΡΡΠ΅ ΠΏΡΠ΅Π½Π΅Π»ΠΈ ΡΠ°ΡΠ»ΠΎΠ²Π΅ Ρ ΠΏΠΎΠ΄ΡΠΆΠ°Π½Π΅ Π΅-ΡΠΈΡΠ°ΡΠ΅.
